- Bevacizumab in first-line therapy for metastatic colorectal cancer in combination with FOLFOX or XELOX2014 | First Faculty of Medicine
- The complete response rate of liver metastasis in patients with metatstatic colorectal cancer treated with the systemic chemotherapy FOLFOX and cetuximab2013 | Publication without faculty affiliation
- Comment to study: A randomized phase |III study of FOLFIRI plus cetuximab or bevacizumab as first-line treatment for wild type (WT) KRAS metastatic colorectal cancer (mCRC) patients: German study AIO KRK-0306(FIRE-3)2013 | First Faculty of Medicine
- FOLFOX/FOLFIRI pharmacogenetics: The call for a personalized approach in colorectal cancer therapy2014 | Faculty of Medicine in Pilsen
- The current view of the pharmacotherapy of inoperable metastatic colorectal cancer2015 | First Faculty of Medicine
- Durable Complete Response of Colorectal Cancer Metastasis after Biochemotherapy2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Physical Education and Sport, Central Library of Charles University
- Nanoliposomal irinotecan in patients with pancreatic cancer - overall survival and results of patients treated according to the protocol in the NAPOLI-1 study2021 | Publication without faculty affiliation
- Cetuximab v léčbě metastatického kolorektálního karcinomu2016 | First Faculty of Medicine
- Efficacy of anti-VEGF therapy with afliberceptem in advanced colorectal cancer2017 | Publication without faculty affiliation
- Pharmacotherapy of colon cancer, rectosigmoid junction and rectum2011 | Publication without faculty affiliation
- Efficacy of anti-VEGF therapy (aflibercept) in advanced colorectal cancer2019 | Publication without faculty affiliation
- Panitumumab in the treatment of colorectal carcinoma2020 | Publication without faculty affiliation
- Panitumumab as first-line treatment of colorectal cancer2019 | Publication without faculty affiliation
- Anti-EGFR treatment of colorectal cancer2021 | Publication without faculty affiliation
- Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis2014 | First Faculty of Medicine
- Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC2019 | First Faculty of Medicine